Moderna CEO touts plan for triple combo respiratory shot in 'three to five years': report

Alongside its planned omicron-targeting shots for this fall, Moderna expects a combination COVID, flu and respiratory syncytial virus shot will be developed over "three to five years," CEO Stéphane Bancel told CNN Business.